Literature DB >> 2463384

Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.

S A Jenison1, X P Yu, J M Valentine, D A Galloway.   

Abstract

Recombinant proteins encoded by the human papillomavirus type 6b (HPV6b) L1 open reading frame react with sera from patients with condylomata acuminata and also react with rabbit antiserum raised against sodium dodecyl sulfate-disrupted bovine papillomavirus type 1 (BPV1) virions. To map the immunoreactive epitopes, a series of procaryotic expression plasmids was made which contained a nested set of 3' to 5' deletions in the HPV6b L1 open reading frame. The deleted plasmids expressed a set of carboxy to amino terminus truncated fusion proteins. Regions containing the immunoreactive epitopes were mapped by determining which of the deleted fusion proteins retained reactivity with sera in Western immunoblot assays. The coding sequence for a human antibody-reactive linear epitope mapped between HPV6b nucleotide coordinates 7045 and 7087, and the rabbit anti-BPV1-reactive epitope coding sequence mapped between coordinates 6377 and 6454. Synthetic peptides derived from the epitope mapping were reacted with sera in enzyme-linked immunosorbent assay. Human sera reacted with synthetic peptide QSQAITCQKPTPEKEKPDPYK (HPV6b L1 amino acids 417 through 437). Rabbit anti-BPV1 and rabbit antisera raised against HPV16 L1 recombinant proteins reacted with the synthetic peptide DGDMVDTGFGAMNFADLQTNKSDVPIDI (HPV6b L1 amino acids 193 through 220). Human sera which reacted with HPV6b L1 fusion proteins cross-reacted with an HPV11 L1 fusion protein but did not react with fusion proteins encoded by HPV1a, HPV16, or HPV18. Rabbit anti-BPV1 reacted with L1 fusion proteins encoded by all of these HPV types. In contrast to the type-common (rabbit anti-BPV1-reactive) epitope, the human antibody-reactive epitope appears to be relatively HPV type specific.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463384      PMCID: PMC247754     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3.

Authors:  I Clark-Lewis; R Aebersold; H Ziltener; J W Schrader; L E Hood; S B Kent
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

2.  Wart-associated antigens. II. Human immunity to viral structural proteins.

Authors:  F Pass; J V Maizel
Journal:  J Invest Dermatol       Date:  1973-05       Impact factor: 8.551

3.  DNA-binding activity of papillomavirus proteins.

Authors:  R G Mallon; D Wojciechowicz; V Defendi
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Laboratory production in vivo of infectious human papillomavirus type 11.

Authors:  J W Kreider; M K Howett; A E Leure-Dupree; R J Zaino; J A Weber
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

5.  The nucleotide sequence and genome organization of human papilloma virus type 11.

Authors:  K Dartmann; E Schwarz; L Gissmann; H zur Hausen
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

6.  Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens.

Authors:  Y Nakai; W D Lancaster; L Y Lim; A B Jenson
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

7.  Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma.

Authors:  R F Rando; D E Groff; J G Chirikjian; W D Lancaster
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  Human papillomaviruses in Buschke-Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype.

Authors:  M Boshart; H zur Hausen
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  Expression of the E2 open reading frame of papilloma viruses BPV1 and HPV6b in Escherichia coli.

Authors:  R G Mallon; W Sisk; V Defendi
Journal:  Gene       Date:  1986       Impact factor: 3.688

10.  Assessing child abuse in childhood condyloma acuminatum.

Authors:  L Schachner; D E Hankin
Journal:  J Am Acad Dermatol       Date:  1985-01       Impact factor: 11.527

View more
  17 in total

1.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.

Authors:  Y L Lin; L A Borenstein; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

3.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.

Authors:  N Yaegashi; S A Jenison; J M Valentine; M Dunn; L B Taichman; D A Baker; D A Galloway
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 4.  Human papillomavirus type 16 E5 protein as a therapeutic target.

Authors:  Sang-Woo Kim; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

5.  Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.

Authors:  C E Greer; C M Wheeler; M B Ladner; K Beutner; M Y Coyne; H Liang; A Langenberg; T S Yen; R Ralston
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 6.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

Review 7.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.

Authors:  M E Hagensee; N Yaegashi; D A Galloway
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33.

Authors:  C Volpers; M Sapp; C A Komly; P Richalet-Secordel; R E Streeck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.

Authors:  L Dillner; A Fredriksson; E Persson; O Forslund; B G Hansson; J Dillner
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.